Slovenia says it could permanently ban Johnson & Johnson’s Janssen COVID-19 after an enquiry established that a woman’s death was linked to its use.
The country temporarily suspended the use of the vaccine after the September incident.
A neurologist said at the time that the victim had developed blood clots and bleeding in the brain.
A commission was subsequently set up to determine whether or not taking the vaccine had anything to do with the victim’s death.
“A commission established to examine the case of the death unanimously concluded that the tragic outcome was related to the vaccine,” commission member Zoran Simonovic was quoted as saying by the national STA news agency on Tuesday.
He disclosed that the woman developed thrombosis after receiving the vaccine.
Thrombosis occurs when blood clots block a patient’s blood vessels.
In response, Johnson & Johnson said “there is greater priority than the safety and well-being of the people we serve, and we carefully review reports of adverse events in individuals receiving our medicines or vaccines.
“Any report about an individual receiving our COVID-19 vaccine and our assessment of that report is shared with the U.S. Food and Drug Administration and other appropriate health authorities.”
Health Minister Janez Poklukar said he would propose prohibiting the vaccine except for cases where an individual specifically requires it.